| Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery Y Zou, J Xie, S Zheng, W Liu, Y Tang, W Tian, X Deng, L Wu, Y Zhang, ... International Journal of Surgery 107, 106936, 2022 | 240 | 2022 |
| circFBXW7 inhibits malignant progression by sponging miR-197-3p and encoding a 185-aa protein in triple-negative breast cancer F Ye, G Gao, Y Zou, S Zheng, L Zhang, X Ou, X Xie, H Tang Molecular Therapy-Nucleic Acids 18, 88-98, 2019 | 220 | 2019 |
| Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study W Xiao, S Zheng, A Yang, X Zhang, Y Zou, H Tang, X Xie Cancer management and research, 5329-5338, 2018 | 196 | 2018 |
| The single‐cell landscape of intratumoral heterogeneity and the immunosuppressive microenvironment in liver and brain metastases of breast cancer Y Zou, F Ye, Y Kong, X Hu, X Deng, J Xie, C Song, X Ou, S Wu, L Wu, ... Advanced Science 10 (5), 2203699, 2023 | 169 | 2023 |
| N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer Y Zou, S Zheng, X Xie, F Ye, X Hu, Z Tian, SM Yan, L Yang, Y Kong, ... Nature communications 13 (1), 2672, 2022 | 149 | 2022 |
| Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis Y Zou, X Zou, S Zheng, H Tang, L Zhang, P Liu, X Xie Therapeutic advances in medical oncology 12, 1758835920940928, 2020 | 125 | 2020 |
| The role of circular RNA CDR1as/ciRS-7 in regulating tumor microenvironment: a pan-cancer analysis Y Zou, S Zheng, X Deng, A Yang, X Xie, H Tang, X Xie Biomolecules 9 (9), 429, 2019 | 108 | 2019 |
| Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population‐based study W Xiao, S Zheng, P Liu, Y Zou, X Xie, P Yu, H Tang, X Xie Cancer medicine 7 (3), 922-930, 2018 | 104 | 2018 |
| Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer S Zheng, L Yang, Y Zou, J Liang, P Liu, G Gao, A Yang, H Tang, X Xie Journal of hematology & oncology 13, 1-15, 2020 | 103 | 2020 |
| Dissection of FOXO1-induced LYPLAL1-DT impeding triple-negative breast cancer progression via mediating hnRNPK/β-catenin complex Y Tang, W Tian, S Zheng, Y Zou, J Xie, J Zhang, X Li, Y Sun, J Lan, N Li, ... Research 6, 0289, 2023 | 89 | 2023 |
| circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression Y Zou, S Zheng, W Xiao, X Xie, A Yang, G Gao, Z Xiong, Z Xue, H Tang, ... Carcinogenesis 40 (12), 1469-1479, 2019 | 75 | 2019 |
| Prognosis and dissection of immunosuppressive microenvironment in breast cancer based on fatty acid metabolism-related signature Y Tang, W Tian, J Xie, Y Zou, Z Wang, N Li, Y Zeng, L Wu, Y Zhang, S Wu, ... Frontiers in immunology 13, 843515, 2022 | 72 | 2022 |
| CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression Y Kong, L Yang, W Wei, N Lyu, Y Zou, G Gao, X Ou, X Xie, H Tang Epigenomics 11 (10), 1163-1176, 2019 | 71 | 2019 |
| CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1 W Xiao, S Zheng, Y Zou, A Yang, X Xie, H Tang, X Xie Aging (Albany NY) 11 (24), 12043, 2019 | 69 | 2019 |
| Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer S Zheng, Y Zou, Y Tang, A Yang, JY Liang, L Wu, W Tian, W Xiao, X Xie, ... Oncoimmunology 11 (1), 2020984, 2022 | 68 | 2022 |
| Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer S Zheng, Y Zou, J Liang, W Xiao, A Yang, T Meng, S Lu, Z Luo, X Xie Molecular oncology 14 (11), 2814-2833, 2020 | 68 | 2020 |
| Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis Y Zou, X Hu, S Zheng, A Yang, X Li, H Tang, Y Kong, X Xie EBioMedicine 63, 2021 | 61 | 2021 |
| Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis W Xiao, Y Zou, S Zheng, X Hu, P Liu, X Xie, P Yu, H Tang, X Xie European Journal of Surgical Oncology 44 (10), 1504-1512, 2018 | 61 | 2018 |
| Advances in artificial intelligence to predict cancer immunotherapy efficacy J Xie, X Luo, X Deng, Y Tang, W Tian, H Cheng, J Zhang, Y Zou, Z Guo, ... Frontiers in immunology 13, 1076883, 2023 | 54 | 2023 |
| circGNB1 facilitates triple-negative breast cancer progression by regulating miR-141-5p-IGF1R axis P Liu, Y Zou, X Li, A Yang, F Ye, J Zhang, W Wei, Y Kong Frontiers in Genetics 11, 193, 2020 | 54 | 2020 |
